<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21669">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01874912</url>
  </required_header>
  <id_info>
    <org_study_id>SO(IRISIN)</org_study_id>
    <nct_id>NCT01874912</nct_id>
  </id_info>
  <brief_title>Human Irisin Concentration in Sarcopenia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Irisin has been identified as a novel myokine that drives brown-fat-like conversion of white
      adipose tissue. In this cross-sectional study, the researches investigated whether serum
      irisin levels are decreased in patients with sarcopenia compared with control subjects with
      normal muscle mass, and assessed the association between serum irisin levels and various
      metabolic parameters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Serum concentration of irisin in the subjects with sarcopenia</measure>
    <time_frame>12 week</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relationship of serum irisin levels with lipid profiles</measure>
    <time_frame>12 week</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationship of serum irisin levels with skeletal muscle mass index</measure>
    <time_frame>12 wks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">406</enrollment>
  <condition>Sarcopenia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in Korean Sarcopenic Obesity Study (KSOS), an prospective observational cohort
        study designed to examine the prevalence of sarcopenia and sarcopenic obesity in Korean
        adults and to evaluate their effects on metabolic disorders and health outcomes.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20&lt;age&lt;80

          -  apparently healthy subjects

        Exclusion Criteria:

          -  a history of cardiovascular disease

          -  diabetes

          -  stage 2 hypertension

          -  malignancy

          -  severe renal or hepatic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 7, 2013</lastchanged_date>
  <firstreceived_date>June 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University</investigator_affiliation>
    <investigator_full_name>K. M. Choi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
